Metropolis Healthcare Ltd a leading diagnostic service provider today announced its un-audited financial results for the quarter ended 30th June 2019.
The company posted its Q1 net profit at Rs26.9cr. The company’s revenue from operations in the quarter stood at Rs203.29cr from Rs175.76cr a year ago.
Ameera Shah, Managing Director of Metropolis Healthcare Ltd said “We are happy to announce our first-quarter results for FY20. Q1 is typically a lean quarter for the industry but we have witnessed a healthy revenue and volume growth. Keeping in line with our growth strategy, we are witnessing an increase in revenue contribution from our retail business, reflecting patient trust and preference for Metropolis. Strong operating parameters gives us comfort that we are moving in the right direction. As a newly listed company and as an organisation with a strong sense of purpose, we are committed to working towards a solid governance framework and strong processes and systems. In addition to creating value for all stakeholders, we will continue to walk the extra mile for our patients who trust us during their most anxious moments during illnesses.”
Metropolis Healthcare Ltd is currently trading at Rs1,042.70, down by Rs6.6 or 0.63% from its previous closing of Rs1,049.30 on the BSE.
The scrip opened at Rs1,040 and has touched a high and low of Rs1,055 and Rs1,030.30 respectively.